BMJ Open· Stevens, N. E., Botten, R., Geake, J. B., Eden, G. L., Lo, W. K., Inauen, J., Solujic, J., Sawka, A., Yelland, L. N., Reid, E. W., Shaw, M., Zhu, X., Tam, T. K., Jeon, H., Amenyogbe, N., Lynn, M. A., Ryan, F. J., Feng, C. G., Britton, W. J., Kollmann, T. R., Barry, S. E., Lynn, D. J.·· 2026-10-15AI 评分15
AVIRS研究方案:评估抗生素破坏肠道菌群是否损害年轻健康成人BCG诱导的特异性及非特异性免疫
A randomised, placebo-controlled study to assess whether antibiotic-mediated disruption of the gut microbiota impairs BCG-induced specific and non-specific immunity in young, healthy adults: protocol for the Antibiotics and Vaccine Immune Responses Study (AVIRS)
AI 导读
AVIRS是一项随机、安慰剂对照研究方案,旨在评估抗生素介导的肠道菌群紊乱是否损害年轻健康成人中BCG疫苗诱导的特异性和非特异性免疫。研究采用受控人类挑战模型及多组学方法,在结核病非流行区招募未接种BCG的健康成人进行因果评价。
来源:BMJ Open · bmjopen.bmj.com